The mutant variant of TP53 promotes tumor cell proliferation and accelerates the malignant transformation of astrocytic tumors [5]. This variation is often connected with the IDH-1 mutation (65%-90% of cases), but the TP53 gene mutation occurs in only 30% of IDH wild-type GBM [6]. This evidence concerns the gene TP53 and neoplasm.